{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:49:02Z","timestamp":1761540542881,"version":"build-2065373602"},"reference-count":12,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":6646,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1111\/j.1538-7836.2004.00930.x","type":"journal-article","created":{"date-parts":[[2004,9,28]],"date-time":"2004-09-28T09:04:57Z","timestamp":1096362297000},"page":"1724-1726","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Is the assessment of von Willebrand disease prevalence an achievable challenge? The example of the French Basque Country where blood group O and factor XI deficiency are highly prevalent"],"prefix":"10.1016","volume":"2","author":[{"given":"F.","family":"Bauduer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Ducout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2004.00930.x_bb0010","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1053\/beha.2001.0136","article-title":"Congenital von Willebrand disease type 1: definition, phenotypes, clinical and laboratory assessment","volume":"14","author":"Rodeghiero","year":"2001","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1111\/j.1538-7836.2004.00930.x_bb0015","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1182\/blood-2002-09-2892","article-title":"von Willebrand disease type 1: a diagnosis in search of a disease","volume":"101","author":"Sadler","year":"2003","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2004.00930.x_bb0020","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1055\/s-0037-1613992","article-title":"Impact, diagnosis and treatment of von Willebrand disease","volume":"84","author":"Sadler","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2004.00930.x_bb0025","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1046\/j.1538-7836.2003.00367.x","article-title":"Measurement of von Willebrand factor activity: relative effects of ABO blood type and race","volume":"1","author":"Miller","year":"2003","journal-title":"J Thromb Haemost"},{"year":"1994","series-title":"The History and Geography of Human Genes","author":"Cavalli\u2010Sforza","key":"10.1111\/j.1538-7836.2004.00930.x_bb0030"},{"key":"10.1111\/j.1538-7836.2004.00930.x_bb0035","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1365-2516.2004.00892.x","article-title":"Is there a \u2018Basque\u2019 profile regarding autosomal recessive deficiencies of coagulation factors?","volume":"10","author":"Bauduer","year":"2004","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2004.00930.x_bb0040","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1182\/blood.V99.7.2448","article-title":"Factor XI deficiency in Basques is predominantly caused by an ancestral C38R mutation in the factor XI gene","volume":"99","author":"Zivelin","year":"2002","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2004.00930.x_bb0045","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1055\/s-0037-1614162","article-title":"Identification of type 2 von Willebrand disease in previously diagnosed type 1 patients: a reappraisal using phenotypes, genotypes and molecular modelling","volume":"84","author":"Nitu\u2010Whalley","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2004.00930.x_bb0050","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1046\/j.1365-2516.2002.00672.x","article-title":"Guidelines for the diagnosis and management of von Willebrand disease in Italy","volume":"8","author":"Federici","year":"2002","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2004.00930.x_bb0055","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1182\/blood.V69.6.1691.1691","article-title":"The effect of ABO blood group on the diagnosis of von Willebrand disease","volume":"69","author":"Gill","year":"1987","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2004.00930.x_bb0060","first-page":"198","article-title":"Is there still a ABO and Rhesus blood groups specificity within the French Basque Country and the \u2018Aquitany perimeter\u2019 at the beginning of the 21st Century?","volume":"14","author":"Bauduer","year":"2002","journal-title":"Bull Mem Soc Anthropol Paris"},{"key":"10.1111\/j.1538-7836.2004.00930.x_bb0065","first-page":"89","article-title":"Factor VIII and factor IX in a twin population: evidence for a major effect of ABO locus on factor VIII level","volume":"37","author":"Orstavik","year":"1985","journal-title":"Am J Hum Genet"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2004.00930.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622181043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622181043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2004.00930.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:31:47Z","timestamp":1761532307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622181043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":12,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["S1538783622181043"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2004.00930.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"type":"print","value":"1538-7836"}],"subject":[],"published":{"date-parts":[[2004,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is the assessment of von Willebrand disease prevalence an achievable challenge? The example of the French Basque Country where blood group O and factor XI deficiency are highly prevalent","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2004.00930.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}